MPWT
SGMO

MassMutual Private Wealth & Trust’s SANGAMO THERAPEUTICS INC SGMO Stock Holding History

MassMutual Private Wealth & Trust’s Portfolio SGMO Stock Details SGMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-275
Closed -$484 – 2003
2023
Q1 		$484 Buy
+275
New +$785 ﹤0.01% 1684

Other funds holding SGMO

WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RCMU
Rokos Capital Management (UK) London, United Kingdom $13.2B AUM 85.71% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

MassMutual Private Wealth & Trust's SGMO Position: Q2 2023 in Review

MassMutual Private Wealth & Trust sold out of SANGAMO THERAPEUTICS INC (SGMO) in Q2 2023, closing a stake of 275 shares — an estimated $484 sold.

MassMutual Private Wealth & Trust first reported a position in SGMO in Q1 2023 and held it in 1 quarter. The position peaked at $484 in Q1 2023. 152 funds tracked by Wall St. Rank hold SGMO as of Q2 2023.

  • MassMutual Private Wealth & Trust reported no remaining SANGAMO THERAPEUTICS INC position as of Q2 2023 after selling out during the quarter.
  • MassMutual Private Wealth & Trust sold 275 SANGAMO THERAPEUTICS INC shares in Q2 2023, an estimated $484.
  • MassMutual Private Wealth & Trust first reported a position in SANGAMO THERAPEUTICS INC in Q1 2023 and held it in 1 quarter.
  • MassMutual Private Wealth & Trust's SANGAMO THERAPEUTICS INC position peaked at $484 in Q1 2023.
  • 152 funds tracked by Wall St. Rank held SANGAMO THERAPEUTICS INC as of Q2 2023.

Based on MassMutual Private Wealth & Trust's 13F filing for Q2 2023, filed 2 Aug 2023.